Robert Hayman - 09 Sep 2022 Form 4 Insider Report for Evolus, Inc. (EOLS)

Role
Director
Signature
/s/ Jeffrey J. Plumer, as attorney-in-fact for Robert Hayman
Issuer symbol
EOLS
Transactions as of
09 Sep 2022
Net transactions value
+$103,938
Form type
4
Filing time
13 Sep 2022, 17:57:28 UTC
Previous filing
13 Sep 2022
Next filing
31 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EOLS Common Stock Purchase $92,182 +8,909 $10.35 8,909 09 Sep 2022 By trust F1, F2
transaction EOLS Common Stock Purchase $11,756 +1,091 +12% $10.78 10,000 12 Sep 2022 By trust F2
holding EOLS Common Stock 39,881 09 Sep 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were purchased in multiple trades at prices ranging from $10.335 to $10.35. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 By the Robert Hayman Living Trust
F3 Total includes 15,568 shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of January 24, 2022, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.